中国药房2012，Vol.23Issue(6)：491-494,4.DOI:10.6039/j.issn.1001-0408.2012.06.04
米曲菌胰酶片治疗功能性消化不良的上市后药物经济学评价
Pharmacoeconomics Evaluation after Being on the Market of Aspergillus Oryzae Enzyme and Pancreatin Tablet for Functional Dyspepsia
摘要
Abstract
OBJECTIVE: To investigate the role of clinical pharmacist in drug therapy in pediatric department. METHODS: Disease course, drug therapy and outcomes were all described. The key points of pharmaceutical care of initial viral encephalitis treatment and anti-infective therapy for ventilator-associated pneumonia were analyzed as well as continuous intravenous administration. RESULTS: Clinical pharmacists provided reasonable medication suggestions in the treatment process of pediatric status epileptics and bacterial and fungal infection, which contributed to evaluating and dealing with adverse drug reaction during the treatment process. CONCLUSIONS: Pediatric clinical pharmacists join in treatment team and cooperate with clinical physicians to determine and adjust drug treatment programs to deal with adverse drug reactions and improve therapeutic efficacy.关键词
消化不良/米曲菌胰酶片/药物经济学/成本-效果分析Key words
Clinical pharmacist/ Pediatric patient/ Viral encephalitis/ Bacterial infection/ Fungal infection/ Pharmaceutical care分类
医药卫生引用本文复制引用
潘岳松,杜忠东,彭晓霞..米曲菌胰酶片治疗功能性消化不良的上市后药物经济学评价[J].中国药房,2012,23(6):491-494,4.基金项目
中国医师协会资助课题(CMDA20090506) （CMDA20090506）
